Carina Biotech submits an Investigational New Drug (IND) application to the US FDA for LGR5-Targeted CAR-T Cell Therapy Candidate
Carina Biotech files its first IND application for a CAR-T cell therapy targeting a solid cancer. The IND application is directed at a first-in-human Phase 1/2a clinical trial in advanced
New cancer therapy brings hope
Story by Hayden Smith, featured in The Weekend Australian, 5 June 2021 Battling blood cancer in my 20s, I put my faith in a clinical trial for a promising new
CAR-T therapy clinical trials to start in Australia in 2019
Off-the-shelf CAR-T therapy clinical trials to start in Australia next year CANCER patients would have access to off-the-shelf immunotherapies to reprogram their immune system to fight tumours at a fraction
Seattle Cancer Trial
Seattle cancer trial ‘very good news’ for young patients More than 90 percent of children and young adults with acute lymphoblastic leukemia, or ALL, are in remission after treatment as